Security key
29089Q105
Emergent BioSolutions Inc. - Common Stock (EBS)
CUSIP: 29089Q105
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 30,424,097
- Total 13F value
- $207,508,937
- Share change
- -5,414,981
- Put/Call ratio
- 515%
- SEC-reported price per share
- $6.82
- Number of holders
- 137
- Value change
- -$26,587,800
- Number of buys
- 81
- Number of sells
- 61
- Shares outstanding
- 51,645,224
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
137
Top holders
10
EBS full security history
Ownership snapshot
Full 13F holder table
Emergent BioSolutions Inc. SEC filings
Emergent BioSolutions Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
14%
CHARLES SCHWAB INVESTMENT MANAGEM...
8%
VANGUARD GROUP INC
6.6%
Avidity Partners Management LP
3.7%
MORGAN STANLEY
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
14%
|
$17,862,325
7,060,208 shares
|
— | 31 Mar 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
8%
|
$10,502,837
4,151,319 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
6.6%
|
$8,631,220
3,411,549 shares
|
— | 31 Mar 2024 |
| Avidity Partners Management LP |
13F
Company
|
3.7%
|
$4,827,240
1,908,000 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
2.5%
|
$3,273,067
1,293,702 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.2%
|
$2,836,961
1,121,195 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
137
Shares
30,424,097
Rows available
137
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
115
Q2 2024 holders
137
Holder diff
22
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|